WVE Wave Life Sciences Ltd
Company Analysis
Latest News
🔴 Wave Life Sciences is trading 5.1% down today alongside biotech sector's 2.08% decline
Wave Life Sciences is trading at $3.18, with a -5.07% move alongside broader biotech sector weakness. - The broader biotech sector is down 2.08%; available...
🟢 Wave Life Sciences is trading 10% up today amid broader biotech strength
Wave Life Sciences is trading at $3.49, up +10.09%, with biotech strength the clearest context; evidence points to a sector-led move, not a confirmed...
🟢 Wave Life Sciences is trading 5% up today amid a biotech sector rally
Wave Life Sciences is trading at $3.33, up 5.05%, as broader biotech strength offers a possible explanation; no clear company-specific catalyst was...
🟢 Wave Life Sciences is trading 5% up in pre-market; UBS initiation may be a catalyst
Wave Life Sciences is trading 5.18% higher at $3.25 in pre-market on October 15, 2026; UBS’s recent initiation is a possible, unconfirmed catalyst. - UBS...
🟢 Wave Life Sciences is trading 8% up in pre-market
Wave Life Sciences is trading at $3.39, up 7.95% in pre-market, with no clear company-specific catalyst identified. - The October 13 announcement that the CEO...
🔴 Wave Life Sciences is trading 5.6% down on October 13
Wave Life Sciences is trading 5.6% lower at $3.10, with no specific cause confirmed. - Biotech-sector weakness may be contributing: the supplied sector...
🔴 Wave Life Sciences is trading 5% down with no clear catalyst identified
Wave Life Sciences is trading at $3.28, down 5.20% during the October 12 session, with no clear company-specific catalyst identified. - Available company news...
🔴 Wave Life Sciences is trading 5.3% down today amid biotech-sector weakness
Wave Life Sciences is trading at $3.55, down 5.33%, during the October 6, 2026 session amid biotech-sector weakness. - The supplied sector context says XBI is...
Wave Life Sciences Gets Wainwright Buy Reaffirmation After FDA WVE-006 Agreement
H.C. Wainwright reiterated its Buy rating on Wave Life Sciences and maintained its $13.00 price target on October 2, 2026. The action followed the company’s...
GSK's Bet on a Wave Liver Drug Lifts Shares, but Can $12 Million Move the Needle for a Company Burning Cash?
Shares of Wave Life Sciences jumped 7.9% to $3.99 in pre-market trading after GSK selected one of Wave's liver-disease drug candidates, triggering a $12...
🟢 Wave Life Sciences is trading 7.3% up today after GSK selected a Wave-developed liver-disease candidate
Wave Life Sciences is trading 7.3% higher at $3.97 now after GSK selected a Wave-developed candidate for a liver-disease indication, triggering a $12 million...
🟢 Wave Life Sciences is trading 8% up in pre-market after GSK selected Wave's liver candidate
Wave Life Sciences is trading 7.90% up at $3.99 before the October 1, 2026 market open after GSK's September 30 selection of its Wave-developed candidate for a...
🟢 Wave Life Sciences is trading 6% up in pre-market on September 30, 2026; catalyst remains unclear
Wave Life Sciences is trading at $3.86, up +6.04% in pre-market, with the reason for the move unclear. - No new company-specific announcement dated September...
🔴 Wave Life Sciences is trading 5% down
Wave Life Sciences is trading at $3.76, a -5.05% change, with no confirmed company-specific announcement explaining the intraday decline. - The price was as...
🔴 Wave Life Sciences is trading 5.06% down today
Wave Life Sciences is trading 5.06% lower at $4.13, and the specific cause of the decline is unclear. - The company announced initiation of a Phase 2a WVE-007...
Wave Life Sciences hits 52-week low, as financial losses offset obesity research
Wave Life Sciences Ltd. reached a new 52-week low of $4.40 on Wednesday, September 16, 2026. The stock dropped from its previous close of $4.58. High trading...
🔴 Wave Life Sciences is trading 5% down today with no clear catalyst identified
On September 2, 2026, Wave Life Sciences is trading 5.13% down now at $4.71, despite broader equity markets and biotech trading higher; no fresh...
🔴 Wave Life Sciences is trading 5% down today without a clear catalyst
Wave Life Sciences is trading 5% down at $5.13, with no clearly reported company-specific announcement, earnings release, regulatory action, or analyst...
🟢 Wave Life Sciences is trading 5.25% up today amid risk-on trading after in-line July CPI
Wave Life Sciences is trading 5.25% up now at $5.31, rebounding amid a broader risk-on session following an in-line July CPI report. - Shares fell 16.89% to...
🟢 Wave Life Sciences is trading 6.05% up in pre-market after 16.89% August 11 drop
Wave Life Sciences is trading at $5.35, up +6.05% in pre-market after rebounding from its 16.89% August 11 decline to $5.04. - Management discussed WVE-007,...